Aclaris Therapeutics has secured an exclusive license from Biosion for the global rights to two new antibodies.
“Lilly Canada stands behind Ebglyss as a first-line biological therapy for the treatment of atopic dermatitis and we remain committed ... via LillyPlus will not change as we tenaciously pursue options ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback